… calling it something, had another cute name for it, but it was gain of function testing. But the disturbing part was that, you know, well, that's disturbing enough, but that They [Pfizer] were also doing it for financial benefit, trying to come up with the next strain. so they could get ahead of it, so they could keep pushing, you know, this vaccine development. Because, you know, ask yourself if they're lying to us about all this stuff, which they are. (02:41–10:44)
CLAIM
Asserts that Pfizer was conducting research for financial gain by developing new strains.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
